Instituto De Investigación Biomédica De Salamanca

This phase 3 trial tests whether giving a higher dose of radiation twice a day can help people with limited-stage small cell lung cancer live longer without the cancer growing. About 300 adults will receive standard chemotherapy plus one of three radiation schedules. The study co…

This trial tests a new treatment called TranspoCART19 for people with B-cell lymphoma that has come back or not responded to standard therapy. The treatment uses a patient's own immune cells, which are modified in a lab to better recognize and attack cancer cells. The study aims …

This study tests a new computer program that helps doctors diagnose blocked heart arteries more accurately using CT scans. The software combines several checks into one step, which may reduce the need for invasive procedures like heart catheterization. Researchers will look at pa…

This study is testing whether a tailored exercise program for adults aged 65 and older living in rural areas can improve their physical fitness and quality of life. Participants will receive a personalized plan including aerobic, strength, balance, and flexibility exercises, and …

This study tests whether a much smaller dose of a dye (indocyanine green) given just before surgery can help surgeons see the bile ducts as clearly as the standard larger dose given hours earlier. About 122 adults having gallbladder removal will be randomly assigned to one of the…

This study looks at blood samples from 350 adults with blood cancer who develop a fever and have very low white blood cells (a condition called febrile neutropenia). The goal is to find patterns of proteins in the blood that can predict if a patient will develop serious complicat…

This study follows 400 adults with long COVID for four years to understand how the condition changes over time. Researchers will look at blood markers, blood vessel health, and fatigue levels. The goal is to find better ways to diagnose and manage long COVID in the future.

This study aims to find biomarkers in blood and tumor tissue that can predict which patients with cutaneous squamous cell carcinoma will respond to the immunotherapy drug cemiplimab, and who might experience side effects. Researchers will use advanced flow cytometry and single-ce…